Biotech Marks Time in Q3  

Oleh:

Lawrence, Stacy

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: Nature Biotechnology: The Science and Business of Biotechnology vol. 23 no. 11 (Nov. 2005), page 1332.
Topik: biotechnology; biotech mark

Ketersediaan

Perpustakaan Pusat (Semanggi) Nomor Panggil: NN9.4 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

In a risk averse market, biotech stock market indices showed sluggish growth, beng out performed broader market indicators. Venture capital funding remained relatively stable but public biotechs were able to take advantage of debt, private investment in public equities (PIPEs) and follow on financing to boost available cash. Funds raised through debt increased by three quarters over the total in Q2...

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali